Editor’s Choice: Developments In Beta Thalassemia, Eosinophilic Esophagitis and Congenital Adrenal Hyperplasia

Happy Friday! This week, we have details on an investigational compound for beta thalassemia. Also, we break down the details of a new study that examines psychiatric illness rates among…

Continue Reading Editor’s Choice: Developments In Beta Thalassemia, Eosinophilic Esophagitis and Congenital Adrenal Hyperplasia
First CAR T-Cell Therapy for Multiple Myeloma Cleared for Use in Japan
source: pixabay.com

First CAR T-Cell Therapy for Multiple Myeloma Cleared for Use in Japan

According to a press release from the pharmaceutical company Bristol Myers Squibb, the company's CAR T-Cell therapy idecabtagene vicleucel (marketed as Abecma) has been approved by the Japanese Ministry of…

Continue Reading First CAR T-Cell Therapy for Multiple Myeloma Cleared for Use in Japan

Editor’s Choice: Can Machine Learning Help Rare Patients Get Diagnosed and Treated Faster?

Happy Friday! October is Dysautonomia Awareness Month. Dysautonomia is a collection of conditions that affect the autonomic nervous system. This can lead to a loss of control of the body's…

Continue Reading Editor’s Choice: Can Machine Learning Help Rare Patients Get Diagnosed and Treated Faster?